NEPHROLOGY DIALYSIS TRANSPLANTATION

NEPHROLOGY DIALYSIS TRANSPLANTATION Journal

publication venue for

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease 2023
BASELINE CHARACTERISTICS OF THE FLOW TRIAL POPULATION: KIDNEY OUTCOMES TRIAL WITH ONCE-WEEKLY SEMAGLUTIDE IN PEOPLE WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE 2022
EFFECTS OF SEMAGLUTIDE AND LIRAGLUTIDE ON URINARY ALBUMIN-TO-CREATININE RATIO (UACR) - A POOLED ANALYSIS OF SUSTAIN 6 AND LEADER 2019
EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES - A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS 2019
EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER 2019
Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme. 24:848-855. 2009

International Standard Serial Number (ISSN)

0931-0509

Electronic International Standard Serial Number (EISSN)

1460-2385

journal abbreviation

NEPHROL DIAL TRANSPL